Literature DB >> 31744945

The Inherited Neuromuscular Disorder GNE Myopathy: Research to Patient Care.

Kapila Awasthi1, Ranjana Arya2, Alok Bhattacharya3, Sudha Bhattacharya4.   

Abstract

Inherited neuromuscular diseases are a heterogeneous group of rare diseases for which the low general awareness leads to frequent misdiagnosis. Advances in DNA sequencing technologies are changing this situation, and it is apparent that these diseases are not as rare as previously thought. Knowledge of the pathogenic variants in patients is helping in research efforts to develop new therapies. Here we present a review of current knowledge in GNE myopathy, a rare neuromuscular disorder caused by mutations in the GNE gene that catalyzes the biosynthesis of sialic acid. The most common initial symptom is foot drop caused by anterior tibialis muscle weakness. There is a progressive wasting of distal skeletal muscles in the lower and upper extremities as well. The quadriceps is relatively spared, which is a distinguishing feature of this disease. The characteristic histological features include autophagic rimmed vacuoles with inclusion bodies. GNE variant analysis of Indian patients has revealed a founder mutation (p.Val727Met) common within the normal Indian populations, especially in the state of Gujurat. We discuss therapeutic options, including metabolite supplementation, pharmacological chaperones, and gene therapy. Initiatives that bring together patients, researchers, and physicians are necessary to improve knowledge and treatment for these rare disorders.

Entities:  

Keywords:  GNE myopathy; gene therapy; genetic disorders; inherited neuromuscular disorders; rare diseases

Mesh:

Substances:

Year:  2019        PMID: 31744945     DOI: 10.4103/0028-3886.271259

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  1 in total

1.  Generation and Characterization of a Skeletal Muscle Cell-Based Model Carrying One Single Gne Allele: Implications in Actin Dynamics.

Authors:  Shamulailatpam Shreedarshanee Devi; Rashmi Yadav; Fluencephila Mashangva; Priyanka Chaudhary; Shweta Sharma; Ranjana Arya
Journal:  Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.